Product Categories
| Country: | China |
|---|---|
| Tel: | 21-61263452 |
| Mobile: | 13641803416 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Company Name: | Shanghai GL Peptide Ltd |
| Tel: | 86-21-61263385 |
| Fax: | 86-21-61263399 |
| Email: | ymbetter@glbiochem |
| WebSite: | http://www.glbiochem.com |
| Nationality: | CHINA |
| Product Name | MF | CAS | Details |
|---|
| Caspase 9 Substrate 1r, fluorogenic;(Ac-LEHD)2-Rh110 | C66H79ClN14O21 | Details |
| Caspase 9 Substrate 2m, fluorogenic;Ac-LEHD-AMC | C33H41N7O11 | 292633-16-0 | Details |
| Caspase-1/Caspase-4 Substrate II, Fluorogenic;Ac-WVAD-AMC | C35H38N6O11 | Details |
| Cathepsin D and E Substrate??;Mca-GKPILFFRLK(Dnp)-r-NH2 | Details |
| Cathepsin L Substrate;FITC-LC-Glu-Lys-Ala-Arg-Val-Leu-Ala-Glu-Ala-Ala-Lys(DABCYL)-OH | Details |
| CbnA Induction Factor;SINSQIGKATSSISKCVFSFFKKC(Disulfidebridge:16-24) | C116H188N30O34S2 | Details |
| Cdc2 Substrate;Ac-SPGRRRRK | C42H79N21O11 | Details |
| CEF8, Influenza Virus NP (383-391);SRYWAIRTR | C54H85N19O13 | 142479-13-8 | Details |
| CEF9, Influenza Virus M1 128-135;ASCMGLIY | C37H60N8O11S2 | Details |
| Cerebral peptide 2;FDFGFAGLDTYDAIHRALEQPARGTSNSGSGYNMLMKMQRH-NH2 | Details |
| Cetrorelix Acetate, Cetrotide; | Details |
| ch β-Amyloid (30-16)??;CTFVRTHIFCKEHQF | Details |
| CONSENSUS B Tat-19;PASQPRGDPTGPKES | C63H102N20O24 | Details |
| CONSENSUS B Tat-18;LSKQPASQPRGDPTG | C64H107N21O23 | Details |
| CONSENSUS B Tat-17;HQVSLSKQPASQPRG | C68H114N24O22 | Details |
| CONSENSUS B Tat-16;DSQTHQVSLSKQPAS | C66H109N21O26 | Details |
| CONSENSUS B Tat-15;RAPQDSQTHQVSLSK | C69H116N24O25 | Details |
| CONSENSUS B Tat-14;RQRRRAPQDSQTHQV | C74H127N33O24 | Details |
| CONSENSUS B Tat-13;RKKRRQRRRAPQDSQ | C78H144N38O22 | Details |
| CONSENSUS B Tat-12;ISYGRKKRRQRRRAP | C81H146N36O19 | Details |
| CONSENSUS B Tat-11;KGLGISYGRKKRRQR | C77H139N31O19 | Details |
| Cdc25C-derived peptide??;5-FAM-VSRSGLYRSPSMPENLNRPR-OH | Details |
| CDK5 Substrate [PK-pT-PKKAKKL], Phosphorylated;PK-pT-PKKAKKL | C53H100N15O15P | Details |
| CDK5 Substrate [PKTPKKAKKL], 5-FAM labeled;5-FAM-PKTPKKAKKL | C74H109N15O18 | Details |
| CDK5 Substrate [PKTPKKAKKL], 5-TMR labeled;5-TMR-PKTPKKAKKL | C82H123N18O18+ | Details |
| CDK5 Substrate [PKTPKKAKKL], Biotinylated;Biotin-PKTPKKAKKL | C63H113N17O14S | Details |
| CDK5 Substrate [PKTPKKAKKL];PKTPKKAKKL | C53H99N15O12 | 164669-07-2 | Details |
| CDK7tide derived peptide, FAM-labeled??;5-FAM-FLAKSFGSPNRAYKK-OH | Details |
| CDK7tide, TAMRA labeled??;5-TAMRA-YSPTSPSYSPTSPSYSPTSPS | Details |
| CDK7tide??;YSPTSPSYSPTSPSYSPTSPS | Details |
| CEA , CAP-1, Carcinoembryonic Antigen; | Details |
| CEA, CAP-1-6-D, [Asp6]-Carcinoembryonic Antigen;YLSGADLNL | C43H68N10O15 | Details |
| CEF Control Peptide Pool; | Details |
| CEF11, Epstein-Barr Virus BMLF1 (280-288);GLCTLVAML | C40H73N9O11S2 | Details |
| CEF12, Epstein-Barr Virus latent NA3B (399-408), AVF;AVFDRKSDAK | C49H81N15O16 | Details |
| CEF14, Epstein-Barr Virus Rta Protein (28-37);DYCNVLNKEF | C55H81N13O18S | Details |
| CEF15, Epstein-Barr Virus Lytic Cycle Protein BZLF-1(190-197);RAKFKQLL | C47H82N14O10 | Details |
| CEF16, Epstein-Barr Virus latent NA-3A (337-347);FLRGRAYGL | C49H77N15O11 | Details |
| Caspase 9 Substrate 1f, fluorogenic;Ac-LEHD-AFC | C33H38F3N7O11 | 210345-03-2 | Details |
| Caspase 8 Substrate 1r-z, fluorogenic;(Z-IETD)2-Rh110 | C74H87ClN10O25 | Details |
| Casein Kinase II Substrate [RRADDSDDDDD], Biotinylated;Biotin-RRADDSDDDDD | C56H85N19O29S | Details |
| Casein Kinase II Substrate [RRADDSDDDDD], Phosphorylated;RRADD-pS-DDDDD | C46H72N17O30P | Details |
| Caspase 3 (Apopain) Substrate 1m, fluorogenic;Caspase1(ICE)Substrate1m,fluorogenic | C35H41N5O12 | Details |
| Caspase 1 (ICE) Substrate 2f, fluorogenic;Ac-YVAD-AFC | C33H36F3N5O10 | 219137-85-6 | Details |
| Caspase 1 (ICE) Substrate 2r, fluorogenic;(Ac-YVAD)2-Rh110 | C66H75ClN10O19 | Details |
| Caspase 1 (ICE) Substrate 3f, fluorogenic;Ac-WEHD-AFC | C38H37F3N8O11 | Details |
| Caspase 1 (ICE) Substrate 3m, fluorogenic;Ac-WEHD-AMC | C38H40N8O11 | 189275-74-9 | Details |
| Caspase 1 (ICE) Substrate 3r, fluorogenic;(Ac-WEHD)2-Rh110 | C76H77ClN16O21 | Details |
| Caspase 1 Inhibitor | C31H45FN4O10 | Details |
| Caspase 1 Inhibitor I | C23H32N4O8 | 143313-51-3 | Details |
| Caspase 2 (ICH-1) Substrate 1f, fluorogenic;Ac-VDVAD-AFC | C33H41F3N6O12 | 210344-94-8 | Details |
| Caspase 2 (ICH-1) Substrate 2, fluorogenic;Mca-VDVADGWK(Dnp)-NH2 | C58H71N13O20 | Details |
| Caspase 2 Substrate 3r;Caspase2Substrate3r | C28H25ClN4O9 | Details |
| Caspase 3 (Apopain) Substrate 1f, fluorogenic;Ac-DEVD-AFC | C30H34F3N5O13 | 201608-14-2 | Details |
| Caspase 3 (Apopain) Substrate 1r-z, fluorogenic;(Z-DEVD)2-Rh110 | C72H79ClN10O27 | Details |
| Caspase 3 (Apopain) Substrate 1z, chromogenic;Z-DEVD-pNA | C32H38N6O14 | Details |
| Caspase 3 (Apopain) Substrate 2, chromogenic;Ac-DQMD-pNA | C26H35N7O12S | Details |
| Caspase 3 Substrate 1, chromogenic;Ac-DMQD-pNA | C26H35N7O12S | 907589-02-0 | Details |
| Caspase 3 Substrate 1f, fluorogenic;Ac-DMQD-AFC | C30H35F3N6O12S | Details |
| Caspase 3 Substrate 1r, fluorogenic;(Ac-DMQD)2-Rh110 | C60H73ClN12O23S2 | Details |
| Caspase 4 (ICH-2) Substrate 1, chromogenic;Ac-LEVD-pNA | C28H40N6O11 | 189684-49-9 | Details |
| Caspase 4 (ICH-2) Substrate 1f, fluorogenic;Ac-LEVD-AFC | C32H40F3N5O11 | 1092077-23-0 | Details |
| Caspase 4 (ICH-2) Substrate 1m, fluorogenic;Ac-LEVD-AMC | C32H43N5O11 | Details |
| Caspase 4 (ICH-2) Substrate 1r, fluorogenic;(Ac-LEVD)2-Rh110 | C64H83ClN10O21 | Details |
| Caspase 6 (Mch2) Substrate 1f, fluorogenic;Ac-VEID-AFC | C32H40F3N5O11 | Details |
| Caspase 6 (Mch2) Substrate 1m, fluorogenic;Ac-VEID-AMC | C32H43N5O11 | 219137-97-0 | Details |
| Caspase 6 (Mch2) Substrate 1r, fluorogenic;(Ac-VEID)2-Rh110 | C64H83ClN10O21 | Details |
| Caspase 8 Substrate 1f, fluorogenic;Ac-IETD-AFC | C31H38F3N5O12 | 211990-57-7 | Details |
| Caspase 8 Substrate 1f-z, fluorogenic;Z-IETD-AFC | C37H42F3N5O13 | 219138-02-0 | Details |
| CONSENSUS B Tat-10;CFTTKGLGISYGRKK | C74H123N21O20S | Details |
| CONSENSUS B Tat-05;QPKTACTNCYCKKCC | C67H112N20O21S5 | Details |
| Chlorotoxin (Cltx)?;MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR-NH2(Disulfidebridge:2-19,5-28,16-33,20-35) | C158H249N53O47S11 | Details |
| CK2tide, FAM-labeled??;5-FAM-RRRADDSDDDDD-NH2 | Details |
| c-Myc peptide epitope;EQKLISEEDL | C51H86N12O21 | Details |
| CONSENSUS B Tat -03;EPWKHPGSQPKTACT | C73H111N21O22S | Details |
| CONSENSUS B Tat-01;MEPVDPRLEPWKHPG | C81H122N22O22S | Details |
| CONSENSUS B Tat-02;DPRLEPWKHPGSQPK | C80H122N24O22 | Details |
| CEF17, Epstein-Barr Virus latent NA-3A (158-166);QAKWRLQTL | C52H86N16O13 | Details |
| CEF18, Epstein-Barr Virus latent NA-3C (258-266);RRIYDLIEL | C54H91N15O15 | Details |
| CEF19, Epstein-Barr Virus latent NA-3A (458-466);YPLHEQHGM | C49H70N14O14S | 157876-41-0 | Details |
| CEF21, Cytomegalovirus, CMV pp65 (417-426);TPRVTGGGAM | C38H67N13O13S | Details |
| CEF22, Cytomegalovirus, CMV pp65 (378-389);SDEEEAIVAYTL | C58H90N12O24 | Details |
| CEF23, Cytomegalovirus, CMV pp65 (123-131);IPSINVHHY | C50H74N14O13 | Details |
| CEF24, Influenza Virus PB1 Peptide (591-599);VSDGGPNLY | C40H60N10O15 | Details |
| CEF25, Influenza Virus NP (44-52);CTELKLSDY | C46H74N10O17S | Details |
| CEF26, Influenza Virus NP (265-274);ILRGSVAHK | C43H77N15O11 | Details |
| CEF27, Epstein-Barr Virus BRLF-1 lytic (148-156);RVRAYTYSK | C51H82N16O14 | 254110-79-7 | Details |
| CEF29, Epstein-Barr Virus latent NA-3B (416-424);IVTDFSVIK | C48H80N10O14 | Details |
| CEF30, Epstein-Barr Virus BRLF1 (134-142);ATIGTAMYK | C42H70N10O13S | Details |
| CEF31, Epstein-Barr Virus latent NA-3A (379-387);RPPIFIRRL | C55H94N18O10 | Details |
| CEF33, Cytomegalovirus, HCMV pp65;EFFWDANDIY | C64H78N12O19 | Details |
| CEF5, Influenza Virus NP (91-99);KTGGPIYKR | C46H78N14O12 | Details |
| CEF7, Influenza Virus NP (380-388);ELRSRYWAI | C55H84N16O14 | 147100-46-7 | Details |
| CONSENSUS B Tat-04;HPGSQPKTACTNCYC | C65H100N20O22S3 | Details |
| Caspase 6 Substrate V, fluorogenic;Ac-VEHD-AFC | C32H36F3N7O11 | 1135418-22-2 | Details |
| CEF32, Epstein-Barr Virus latent NA-3C (281-290);EENLLDFVRF | C59H88N14O18 | Details |
| CEF28, Epstein-Barr Virus latent NA-3A (603-611);RLRAEAQVK | C45H83N17O13 | Details |
| CEF2, Influenza Virus PA (46-54);FMYSDFHFI | C60H75N11O14S | Details |
| Caspase 3 (163-175);CRGTELDCGIETD | C54H90N16O24S2 | Details |
| Casein Kinase II Substrate [RRADDSDDDDD], 5-TMR labeled;5-TMR-RRADDSDDDDD | C75H95ClN20O33 | Details |
| Product Total： Product Page： | ||||
| 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 | ||||